These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 7509621)

  • 1. BCNU-resistant human glioma cells with over-representation of chromosomes 7 and 22 demonstrate increased copy number and expression of platelet-derived growth factor genes.
    Scheck AC; Mehta BM; Beikman MK; Shapiro JR
    Genes Chromosomes Cancer; 1993 Nov; 8(3):137-48. PubMed ID: 7509621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Over-representation of specific regions of chromosome 22 in cells from human glioma correlate with resistance to 1,3-bis(2-chloroethyl)-1-nitrosourea.
    Hank NC; Shapiro JR; Scheck AC
    BMC Cancer; 2006 Jan; 6():2. PubMed ID: 16393339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromosome number and carmustine sensitivity in human gliomas.
    Shapiro JR; Pu PY; Mohamed AN; Galicich JH; Ebrahim SA; Shapiro WR
    Cancer; 1993 Jun; 71(12):4007-21. PubMed ID: 8389658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelial cell hyperplasia in human glioblastoma: coexpression of mRNA for platelet-derived growth factor (PDGF) B chain and PDGF receptor suggests autocrine growth stimulation.
    Hermansson M; Nistér M; Betsholtz C; Heldin CH; Westermark B; Funa K
    Proc Natl Acad Sci U S A; 1988 Oct; 85(20):7748-52. PubMed ID: 2845420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Splicing of the platelet-derived-growth-factor A-chain mRNA in human malignant mesothelioma cell lines and regulation of its expression.
    Langerak AW; Dirks RP; Versnel MA
    Eur J Biochem; 1992 Sep; 208(3):589-96. PubMed ID: 1396665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of cellular pathways involved in glioblastoma response to the chemotherapeutic agent 1, 3-bis(2-chloroethyl)-1-nitrosourea (BCNU) by gene expression profiling.
    Rhee CH; Ruan S; Chen S; Chenchik A; Levin VA; Yung AW; Fuller GN; Zhang W
    Oncol Rep; 1999; 6(2):393-401. PubMed ID: 10023010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BCNU-sensitivity in parental cells and clones from four freshly resected near-diploid human gliomas: an astrocytoma, an anaplastic astrocytoma and two glioblastomas multiforme.
    Shapiro JR; Ebrahim SA; Mohamed AN; Pu PY; Shapiro WR
    J Neurooncol; 1993 Mar; 15(3):209-27. PubMed ID: 8395568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of transforming growth factor-beta1-binding protein overexpression in carmustine-resistant glioma cells by MRNA differential display.
    Norman SA; Rhodes SN; Treasurywala S; Hoelzinger DB; Rankin Shapiro J; Scheck AC
    Cancer; 2000 Aug; 89(4):850-62. PubMed ID: 10951349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of differential expression of platelet-derived growth factor alpha- and beta-receptor mRNA in normal and malignant human mesothelial cell lines.
    Langerak AW; van der Linden-van Beurden CA; Versnel MA
    Biochim Biophys Acta; 1996 Feb; 1305(1-2):63-70. PubMed ID: 8605252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for progressional changes in the human malignant glioma line U-343 MGa: analysis of karyotype and expression of genes encoding the subunit chains of platelet-derived growth factor.
    Nistér M; Wedell B; Betsholtz C; Bywater M; Pettersson M; Westermark B; Mark J
    Cancer Res; 1987 Sep; 47(18):4953-60. PubMed ID: 3497714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transforming growth factor beta as a potential tumor progression factor among hyperdiploid glioblastoma cultures: evidence for the role of platelet-derived growth factor.
    Jennings MT; Hart CE; Commers PA; Whitlock JA; Martincic D; Maciunas RJ; Moots PL; Shehab TM
    J Neurooncol; 1997 Feb; 31(3):233-54. PubMed ID: 9049853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth factor production by human thyroid carcinoma cells: abundant expression of a platelet-derived growth factor-B-like protein by a human papillary carcinoma cell line.
    Matsuo K; Tang SH; Sharifi B; Rubin SA; Schreck R; Fagin JA
    J Clin Endocrinol Metab; 1993 Oct; 77(4):996-1004. PubMed ID: 8408476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptional control of the platelet-derived growth factor subunit genes.
    Kaetzel DM; Coyne DW; Fenstermaker RA
    Biofactors; 1993 May; 4(2):71-81. PubMed ID: 8347277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of a new human glioblastoma cell line that expresses mutant p53 and lacks activation of the PDGF pathway.
    Gjerset RA; Fakhrai H; Shawler DL; Turla S; Dorigo O; Grover-Bardwick A; Mercola D; Wen SF; Collins H; Lin H
    In Vitro Cell Dev Biol Anim; 1995 Mar; 31(3):207-14. PubMed ID: 7757303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human ovarian tumors of epithelial origin express PDGF in vitro and in vivo.
    Versnel MA; Haarbrink M; Langerak AW; de Laat PA; Hagemeijer A; van der Kwast TH; van den Berg-Bakker LA; Schrier PI
    Cancer Genet Cytogenet; 1994 Mar; 73(1):60-4. PubMed ID: 8174076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of c-sis (PDGF B-chain) and PDGF A-chain genes in ten human malignant mesothelioma cell lines derived from primary and metastatic tumors.
    Versnel MA; Hagemeijer A; Bouts MJ; van der Kwast TH; Hoogsteden HC
    Oncogene; 1988 Jun; 2(6):601-5. PubMed ID: 3290807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Excision repair cross-complementing rodent repair deficiency gene 2 expression and chloroethylnitrosourea resistance in human glioma cell lines.
    Chen ZP; McQuillan A; Mohr G; Panasci LC
    Neurosurgery; 1998 May; 42(5):1112-9. PubMed ID: 9588557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased sensitivity to the platelet-derived growth factor (PDGF) receptor inhibitor STI571 in chemoresistant glioma cells is associated with enhanced PDGF-BB-mediated signaling and STI571-induced Akt inactivation.
    Servidei T; Riccardi A; Sanguinetti M; Dominici C; Riccardi R
    J Cell Physiol; 2006 Jul; 208(1):220-8. PubMed ID: 16575905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpressed WAF1/Cip1 renders glioblastoma cells resistant to chemotherapy agents 1,3-bis(2-chloroethyl)-1-nitrosourea and cisplatin.
    Ruan S; Okcu MF; Ren JP; Chiao P; Andreeff M; Levin V; Zhang W
    Cancer Res; 1998 Apr; 58(7):1538-43. PubMed ID: 9537261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response of low-passage human malignant gliomas in vitro to stimulation and selective inhibition of growth factor-mediated pathways.
    Pollack IF; Randall MS; Kristofik MP; Kelly RH; Selker RG; Vertosick FT
    J Neurosurg; 1991 Aug; 75(2):284-93. PubMed ID: 1649272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.